Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
Saved in:
| Title: | Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men. |
|---|---|
| Authors: | Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Metch B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Bekker LG; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Churchyard G; Aurum Institute for Health Research, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; London School of Hygiene and Tropical Medicine, London, United Kingdom., Nchabeleng M; Mecru Clinical Research Unit, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Mlisana K; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., Roux S; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa., Mngadi K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa., Innes C; Aurum Institute Clinical Research Site, Klerksdorp, South Africa., Mathebula M; Mecru Clinical Research Unit, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Allen M; Vaccine Research Program, Division of AIDS, NIAID, NIH, Rockville, United States of America., Bentley C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Robertson M; Merck Research Laboratories, West Point, Pennsylvania, United States of America., Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; South African Medical Research Council, Cape Town, South Africa. |
| Source: | PloS one [PLoS One] 2015 Sep 14; Vol. 10 (9), pp. e0137666. Date of Electronic Publication: 2015 Sep 14 (Print Publication: 2015). |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
